| Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: an-open label, add-on, pilot study A Shelef, Y Barak, U Berger, D Paleacu, S Tadger, I Plopsky, Y Baruch Journal of Alzheimer's disease 51 (1), 15-19, 2016 | 134 | 2016 |
| Equine assisted therapy for patients with post traumatic stress disorder: a case series study A Shelef, D Brafman, T Rosing, A Weizman, R Stryjer, Y Barak Military medicine 184 (9-10), 394-399, 2019 | 54 | 2019 |
| An open-label trial of sildenafil addition in risperidone-treated male schizophrenia patients with erectile dysfunction A Aviv, A Shelef, A Weizman Journal of Clinical Psychiatry 65 (1), 97-103, 2004 | 46 | 2004 |
| Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission rates of older patients with severe mental illness A Shelef, D Mazeh, U Berger, Y Baruch, Y Barak The journal of ECT 31 (2), 125-128, 2015 | 36 | 2015 |
| Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression M Zucker, A Aviv, A Shelef, A Weizman, M Rehavi Psychiatry research 112 (3), 251-256, 2002 | 36 | 2002 |
| Therapist-patient sexual relations: results of a national survey in Israel A Aviv, J Levine, A Shelef, N Speiser, A Elizur Israel Journal of psychiatry and related sciences 43 (2), 119, 2006 | 19 | 2006 |
| Psychosocial and medical aspects of older suicide completers in Israel: A 10‐year survey A Shelef, J Hiss, G Cherkashin, U Berger, D Aizenberg, Y Baruch, Y Barak International journal of geriatric psychiatry 29 (8), 846-851, 2014 | 18 | 2014 |
| Medical grade cannabis (MGC): regulation mechanisms, the present situation around the world and in Israel A Shelef, M Mashiah, I Schumacher, O Shine, Y Baruch Harefuah 150 (12), 913-7, 935, 934, 2011 | 16 | 2011 |
| Immune-related biomarkers and suicidal behaviors: a meta-analysis SP Neupane, FM Daray, ED Ballard, H Galfalvy, L Itzhaky, A Segev, ... European Neuropsychopharmacology 75, 15-30, 2023 | 15 | 2023 |
| A pilot study of cognitive impairment in longstanding electroconvulsive therapy–treated schizophrenia patients versus controls R Danenberg, L Ruimi, A Shelef, DP Kertesz The Journal of ECT 37 (1), 24-29, 2021 | 12 | 2021 |
| Deliberate Self-Harm in Older Adults: A General Hospital Emergency Department Survey. I Briskman, A Shelef, U Berger, Y Baruch, G Bar, J Asherov, A Lvovski, ... The Israel Medical Association Journal: IMAJ 19 (3), 160-163, 2017 | 11 | 2017 |
| A double-blind, placebo-controlled trial of bupropion add-on to olanzapine or risperidone in overweight individuals with schizophrenia S Weizman, A Shelef, EB Bris, R Stryjer Journal of Clinical Psychopharmacology 41 (6), 629-631, 2021 | 8 | 2021 |
| Reducing stigma toward psychiatry among medical students: a multicenter controlled trial D Amsalem, D Gothelf, A Dorman, Y Goren, O Tene, A Shelef, I Horowitz, ... The Primary Care Companion for CNS Disorders 22 (2), 22998, 2020 | 8 | 2020 |
| The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study DS Rubin-Kahana, A Shelef, A Weizman, D Gothelf, I Timinski, B Spivak, ... International Clinical Psychopharmacology 34 (4), 179-183, 2019 | 7 | 2019 |
| Add-on benzodiazepines for psychosis-induced aggression S Baranchik, R Stryjer, A Weizman, A Shelef International Clinical Psychopharmacology 34 (3), 119-123, 2019 | 6 | 2019 |
| Factors affecting the willingness of mental health staff to get vaccinated against COVID‐19 S Dahan, E Bloemhof‐Bris, S Weizman, M Pesah, N Gorno, M Abu Shah, ... Journal of Evaluation in Clinical Practice 28 (6), 948-957, 2022 | 3 | 2022 |
| Happiness amongst Israel Defense Force (IDF) mental health officers (MHO’s) A Shelef, C Zdaka, Y Barak Disaster and military medicine 1, 1-4, 2015 | 3 | 2015 |
| Vitamin D as a Protective Factor in COVID-19 Infection in Elderly Schizophrenia and Dementia Inpatients: A Case Series. A Shelef, S Dahan, S Weizman The Israel Medical Association Journal: IMAJ 24 (2), 74-77, 2022 | 2 | 2022 |
| Creatine kinase levels in psychotic patients who use cannabinoids A Fruman, R Stryjer, S Weizman, A Shelef International Clinical Psychopharmacology 36 (1), 45-49, 2021 | 1 | 2021 |
| Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy E Bloemhof-Bris, D Meiri, L Sulimani, SN Genesh, G Wexler, I Cohen, ... Psychiatry Research 337, 115967, 2024 | | 2024 |
Abraham WeizmanProfessor of Psychiatry, Tel Aviv University, Tel Aviv, Israel在 post.tau.ac.il 的电子邮件经过验证
